Nalaganje...

Using proteomics as a powerful tool to develop a vaccine against Mediterranean visceral leishmaniasis

Visceral leishmaniasis (VL) is a tropical infectious disease, which is called Mediterranean visceral leishmaniasis (MVL) in the Mediterranean area. In spite of many attempts, no effective commercial vaccine exists for MVL. To find new targets for developing antileishmanial vaccines, knowing parasite...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Parasit Dis
Main Authors: Rashidi, Sajad, Kalantar, Kurosh, Hatam, Gholamreza
Format: Artigo
Jezik:Inglês
Izdano: Springer India 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5962495/
https://ncbi.nlm.nih.gov/pubmed/29844618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12639-018-0986-y
Oznake: Označite
Brez oznak, prvi označite!